B2I - Bridge 2 Industry

AllCells is a private biotechnology company that supplies primary cells for scientific research applications in the areas of cell biology, oncology, virology, hematology, infectious diseases, and stem cell research. Founded in 1998, AllCells is dedicated to providing global researchers and biomanufacturing organizations with a dependable supply of biologically relevant, high quality primary cells that enable drug discovery, development, and manufacturing of cell therapies. Learn more about AllCells at www.allcells.com

Celgene is an established bio-pharmaceutical company that develops drugs for the treatment of cancers and inflammatory diseases. The company has recently been acquired by Bristol-Myers Squibb in one of the largest pharmaceutical acquisitions in history. The company has over 7000 employees and a market capitalization of $60B on Nasdaq.